Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636316011 | Omalizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4636317019 | Product containing only omalizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5300961000052118 | läkemedel som endast innehåller omalizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Omalizumab only product in parenteral dose form | Is a | Omalizumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Omalizumab only product in parenteral dose form | Is a | Product containing only omalizumab (medicinal product) | true | Inferred relationship | Some | ||
| Omalizumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Omalizumab only product in parenteral dose form | Has active ingredient | Omalizumab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely omalizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Omalizumab only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR